Anjali Seth

Anjali Seth is currently the Head of Single Cell Proteomics in Cellenion, Lyon, France. She graduated with a Master's in Inorganic and Physical Chemistry from Ecole Normale Supérieure de Paris in 2010. She then obtained a PhD from Pierre and Marie Curie University for her research on magnetic nanoparticles for targeted drug delivery in collaboration with the pharmaceutical company Servier. Next, she underwent a two-year postdoctoral project in Oxford where she used magnetic particles and ultrasound for cancer theranostics. Thereafter, she went back to France, at the Ecole Centrale de Lyon, to work on the creation of cell aggregates by electrophoresis in microfluidic chips. In 2019 she joined Cellenion, a company specialized in the fields of single-cell isolation, to develop and lead the single cell proteomics R&D department.